Abstract: A wheel cover assembly has a mounting ring, an outer wheel cover, and an inner wheel locking structure. The mounting ring attaches to a vehicle wheel hub via latch mechanisms that latch over an axle flange of the wheel hub. The outer wheel cover has axially-inwardly-extending latches that secure the outer wheel cover to the mounting ring. The inner wheel locking structure includes axially-inwardly-extending latches that pass through openings in the outer wheel cover, securing the outer wheel cover to the mounting ring. The inner locking structure includes latches that pass through openings in the outer wheel cover. This inner locking structure includes locking pins that extend into the locking ring to lock the wheel cover latches to the mounting ring. A pair of inner locking faces on the inner locking structure lock the mounting ring latches to the wheel hub.

Abstract: A wheel cover assembly has a mounting ring, an outer wheel cover, and an inner wheel locking structure. The mounting ring attaches to a vehicle wheel hub via latch mechanisms that latch over an axle flange of the wheel hub. The outer wheel cover has axially-inwardly-extending latches that secure the outer wheel cover to the mounting ring. The inner wheel locking structure includes axially-inwardly-extending latches that pass through openings in the outer wheel cover, securing the outer wheel cover to the mounting ring. The inner locking structure includes latches that pass through openings in the outer wheel cover. This inner locking structure includes locking pins that extend into the locking ring to lock the wheel cover latches to the mounting ring. A pair of inner locking faces on the inner locking structure lock the mounting ring latches to the wheel hub.

Abstract: A wheel cover assembly has a mounting ring, an outer wheel cover, and an inner wheel locking structure. The mounting ring attaches to a vehicle wheel hub via latch mechanisms that latch over an axle flange of the wheel hub. The outer wheel cover has axially-inwardly-extending latches that secure the outer wheel cover to the mounting ring. The inner wheel locking structure includes axially-inwardly-extending latches that pass through openings in the outer wheel cover, securing the outer wheel cover to the mounting ring. The inner locking structure includes latches that pass through openings in the outer wheel cover. This inner locking structure includes locking pins that extend into the locking ring to lock the wheel cover latches to the mounting ring. A pair of inner locking faces on the inner locking structure lock the mounting ring latches to the wheel hub.

Abstract: A wheel cover assembly has a mounting ring, an outer wheel cover, and an inner wheel locking structure. The mounting ring attaches to a vehicle wheel hub via latch mechanisms that latch over an axle flange of the wheel hub. The outer wheel cover has axially-inwardly-extending latches that secure the outer wheel cover to the mounting ring. The inner wheel locking structure includes axially-inwardly-extending latches that pass through openings in the outer wheel cover, securing the outer wheel cover to the mounting ring. The inner locking structure includes latches that pass through openings in the outer wheel cover. This inner locking structure includes locking pins that extend into the locking ring to lock the wheel cover latches to the mounting ring. A pair of inner locking faces on the inner locking structure lock the mounting ring latches to the wheel hub.

Abstract: The present disclosure is directed to antibodies binding to ELTDI. Plexin-B2, Spondin-1, fibulin-1, LINGO I or SLIT3 and methods of using such antibodies to treat and/or diagnose gliomas. Thus, in accordance with the present disclosure, there is provided a method of inhibiting a glioma cell comprising contacting said glioma cell with a first antibody or antibody fragment that binds immunologically to ELTDI, Plexin-B2, Spondin-1 or SLIT3. The method may further comprise contacting said glioma cell with a second anti-cancer agent or treatment.

Abstract: The present disclosure is directed to antibodies binding to ELTDI. Plexin-B2, Spondin-1, fibulin-1, LINGO I or SLIT3 and methods of using such antibodies to treat and/or diagnose gliomas. Thus, in accordance with the present disclosure, there is provided a method of inhibiting a glioma cell comprising contacting said glioma cell with a first antibody or antibody fragment that binds immunologically to ELTDI, Plexin-B2, Spondin-1 or SLIT3. The method may further comprise contacting said glioma cell with a second anti-cancer agent or treatment.

Abstract: A microarray database (MDB) system for providing a computer-based environment for storing, managing and interconnecting comprehensive information associated with various aspects of microarray research for a plurality of users, including microarray design and production, sample production, hybridization, data recordation, data retrieval, data analysis, and data presentation. As such, the MDB system gives users the ability to relate information describing array production, experimentation, and analysis, including all the experiment parameters, hybridization results, and analysis results. The MDB system includes a server and database accessible by users via a user system, and provides users with a user interface to input, store, manage, retrieve, process, analyze, display and/or output data relating to microarray experiments.